InterOcean Capital LLC Takes Position in CVS Health Corp (CVS)

InterOcean Capital LLC acquired a new position in shares of CVS Health Corp (NYSE:CVS) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 3,786 shares of the pharmacy operator’s stock, valued at approximately $299,000.

Other hedge funds have also bought and sold shares of the company. City Holding Co. increased its position in shares of CVS Health Corp by 41.3% in the third quarter. City Holding Co. now owns 15,329 shares of the pharmacy operator’s stock worth $1,364,000 after buying an additional 4,479 shares during the last quarter. Hills Bank & Trust Co. increased its position in shares of CVS Health Corp by 5.3% in the third quarter. Hills Bank & Trust Co. now owns 31,595 shares of the pharmacy operator’s stock worth $2,812,000 after buying an additional 1,580 shares during the last quarter. Searle & CO. purchased a new position in shares of CVS Health Corp during the third quarter worth $2,362,000. Stillwater Capital Advisors LLC increased its position in shares of CVS Health Corp by 32.6% in the third quarter. Stillwater Capital Advisors LLC now owns 115,061 shares of the pharmacy operator’s stock worth $10,239,000 after buying an additional 28,289 shares during the last quarter. Finally, Advisory Services Network LLC increased its position in shares of CVS Health Corp by 33.9% in the third quarter. Advisory Services Network LLC now owns 14,062 shares of the pharmacy operator’s stock worth $1,251,000 after buying an additional 3,558 shares during the last quarter. Institutional investors own 81.29% of the company’s stock.

Institutional Ownership by Quarter for CVS Health Corp (NYSE:CVS)

Shares of CVS Health Corp (NYSE:CVS) opened at 78.82 on Tuesday. The company has a market cap of $83.63 billion, a PE ratio of 16.06 and a beta of 0.85. CVS Health Corp has a 12 month low of $69.30 and a 12 month high of $106.67. The stock has a 50 day moving average of $79.27 and a 200-day moving average of $82.31.

CVS Health Corp (NYSE:CVS) last issued its earnings results on Thursday, February 9th. The pharmacy operator reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.67 by $0.04. CVS Health Corp had a return on equity of 17.55% and a net margin of 3.00%. The company had revenue of $46 billion for the quarter, compared to analysts’ expectations of $46.56 billion. During the same period last year, the business earned $1.53 EPS. CVS Health Corp’s quarterly revenue was up 11.7% compared to the same quarter last year. Equities analysts forecast that CVS Health Corp will post $5.86 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, May 1st. Investors of record on Friday, April 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date is Wednesday, April 19th. CVS Health Corp’s dividend payout ratio is currently 40.65%.

Your IP Address:

CVS has been the topic of a number of recent analyst reports. Bank of America Corp restated a “buy” rating and set a $106.67 target price on shares of CVS Health Corp in a report on Tuesday, February 28th. Robert W. Baird downgraded shares of CVS Health Corp from an “outperform” rating to a “neutral” rating and lowered their target price for the stock from $86.00 to $77.00 in a report on Thursday, February 2nd. Vetr downgraded shares of CVS Health Corp from a “buy” rating to a “hold” rating and set a $82.61 target price on the stock. in a report on Tuesday, January 3rd. Jefferies Group LLC initiated coverage on shares of CVS Health Corp in a report on Monday, December 12th. They set a “hold” rating and a $82.00 target price on the stock. Finally, Oppenheimer Holdings Inc. set a $88.00 target price on shares of CVS Health Corp and gave the stock a “buy” rating in a report on Sunday, December 18th. Eight investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $95.99.

In other CVS Health Corp news, EVP Andrew Sussman sold 14,104 shares of the firm’s stock in a transaction on Monday, March 13th. The stock was sold at an average price of $80.40, for a total transaction of $1,133,961.60. Following the transaction, the executive vice president now directly owns 22,801 shares in the company, valued at approximately $1,833,200.40. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO David M. Denton sold 95,618 shares of the firm’s stock in a transaction on Friday, March 10th. The shares were sold at an average price of $80.68, for a total value of $7,714,460.24. Following the transaction, the chief financial officer now owns 250,335 shares in the company, valued at $20,197,027.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 176,947 shares of company stock worth $14,224,010. Company insiders own 0.58% of the company’s stock.

CVS Health Corp Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

5 Day Chart for NYSE:CVS

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2024663/interocean-capital-llc-takes-position-in-cvs-health-corp-cvs.html

Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.